全文获取类型
收费全文 | 167篇 |
免费 | 6篇 |
专业分类
儿科学 | 13篇 |
妇产科学 | 2篇 |
基础医学 | 6篇 |
口腔科学 | 2篇 |
临床医学 | 9篇 |
内科学 | 82篇 |
皮肤病学 | 17篇 |
神经病学 | 4篇 |
特种医学 | 9篇 |
外科学 | 17篇 |
综合类 | 2篇 |
预防医学 | 1篇 |
眼科学 | 5篇 |
药学 | 3篇 |
肿瘤学 | 1篇 |
出版年
2023年 | 1篇 |
2020年 | 4篇 |
2019年 | 2篇 |
2018年 | 2篇 |
2017年 | 1篇 |
2015年 | 3篇 |
2014年 | 3篇 |
2013年 | 5篇 |
2012年 | 3篇 |
2011年 | 5篇 |
2010年 | 1篇 |
2009年 | 1篇 |
2008年 | 10篇 |
2007年 | 10篇 |
2006年 | 7篇 |
2005年 | 10篇 |
2004年 | 10篇 |
2003年 | 8篇 |
2002年 | 8篇 |
2001年 | 9篇 |
2000年 | 8篇 |
1999年 | 7篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1993年 | 2篇 |
1992年 | 6篇 |
1991年 | 4篇 |
1990年 | 4篇 |
1989年 | 3篇 |
1988年 | 3篇 |
1987年 | 5篇 |
1986年 | 10篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 2篇 |
1982年 | 4篇 |
1980年 | 2篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 4篇 |
排序方式: 共有173条查询结果,搜索用时 15 毫秒
171.
172.
Hassanein TI Tofteng F Brown RS McGuire B Lynch P Mehta R Larsen FS Gornbein J Stange J Blei AT 《Hepatology (Baltimore, Md.)》2007,46(6):1853-1862
Extracorporeal albumin dialysis (ECAD) may improve severe hepatic encephalopathy (HE) in patients with advanced cirrhosis via the removal of protein or non-protein-bound toxins. A prospective, randomized, controlled, multicenter trial of the efficacy, safety, and tolerability of ECAD using molecular adsorbent recirculating system (MARS) was conducted in such patients. Patients were randomized to ECAD and standard medical therapy (SMT) or SMT alone. ECAD was provided daily for 6 hours for 5 days or until the patient had a 2-grade improvement in HE. HE grades (West Haven criteria) were evaluated every 12 hours using a scoring algorithm. The primary endpoint was the difference in improvement proportion of HE between the 2 groups. A total of 70 subjects [median age, 53; 56% male; 56% HE grade 3; 44% HE grade 4; median model for end-stage liver disease (MELD) 32 (11-50) and CPT 13 (10-15)] were enrolled in 8 tertiary centers. Patients were randomized to ECAD + SMT (n = 39) or SMT alone (n = 31). Groups were matched in demographics and clinical variables. The improvement proportion of HE was higher in ECAD (mean, 34%; median, 30%) versus the SMT group (mean, 18.9%; median, 0%) (P = 0.044) and was reached faster and more frequently than in the SMT group (P = 0.045). Subjects receiving ECAD tolerated treatment well with no unexpected adverse events. Conclusion: The use of ECAD may be associated with an earlier and more frequent improvement of HE (grade 3/4). Because this 5-day study was not designed to examine the impact of MARS on survival, a full assessment of the role of albumin dialysis awaits the results of additional controlled trials. 相似文献
173.
Jeffrey W. Walter Francine Blei Jennifer L. Anderson Seth J. Orlow Marcy C. Speer Douglas A. Marchuk 《American journal of medical genetics. Part A》1999,82(1):77-83
Infantile hemangiomas are the most common tumor of infancy, occurring with an incidence of up to 10% of all births. They are benign but highly proliferative lesions involving aberrant localized growth of capillary endothelium. Although most hemangiomas occur sporadically and as single lesions, or in conjunction with pleiotropic genetic syndromes, we have previously identified six kindreds where hemangiomas appear to segregate as an autosomal dominant trait with high penetrance. Four such families contain affected individuals in three or more generations. In the current study, blood samples from five of these families were collected and used in a whole genome linkage search at 10-cM resolution. We established evidence for linkage to 5q in three families, and evidence for locus heterogeneity. The three 5q-linked families were further genotyped to generate haplotype information and narrow the candidate interval. Based on recombination breakpoint analysis, the interval exists between markers D5S2490 and D5S408, spanning 55 cM, and corresponding to 5q31-33. Using information from affected and uaffected individuals, the interval spans 38 cM between markers D5S1469 and D5S211. Three candidate genes involved with blood vessel growth map to this region: fibroblast growth factor receptor-4 (FGFR4), platelet-derived growth factor receptor-beta (PDGFRB), and fms-related tyrosine kinase-4 (FLT4). The genes and gene products associated with familial hemangiomas may be involved somatically in the more common sporadic cases. Am. J. Med. Genet. 82:77–83, 1999. © 1999 Wiley-Liss, Inc. 相似文献